The capability of STGIC is validated indirectly by expression of marker genes of invasive breast tumor in the predicted spatial domains (Fig 7C), which are C6orf141, PDE5A, LINC00645, BMERB1, ABCC11, ABCC12 [21, 22, 33, 34]. The gene discussed is PDE5A; the disease is breast neoplasm.